Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2020-03-26 2020-03-25
Drug Identification Number 02238525 02238525
Brand name HP-PAC HP-PAC
Common or Proper name AMOXICILLIN, LANSOPRAZOLE, CLARITHROMYCIN AMOXICILLIN, LANSOPRAZOLE, CLARITHROMYCIN
Company Name TAKEDA PHARMACEUTICALS AMERICA INC TAKEDA PHARMACEUTICALS AMERICA INC
Ingredients AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN
Strength(s) 500MG 30MG 500MG 500MG 30MG 500MG
Dosage form(s) KIT CAPSULE TABLET CAPSULE (DELAYED RELEASE) KIT CAPSULE TABLET CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size HP PAC 7DAY THERAPY HP PAC 7DAY THERAPY
ATC code A02BD A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-24 2020-01-24
Estimated end date Unknown Unknown
Actual end date 2020-03-25 2020-03-25
Shortage status Resolved Actual shortage
Company comments product to be discontinued product to be discontinued
Health Canada comments